vs

Side-by-side financial comparison of MEDIFAST INC (MED) and Quipt Home Medical Corp. (QIPT). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $49.0M, roughly 1.5× Quipt Home Medical Corp.). On growth, Quipt Home Medical Corp. posted the faster year-over-year revenue change (32.3% vs -36.9%). Quipt Home Medical Corp. produced more free cash flow last quarter ($6.9M vs $-6.6M).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Quipt Home Medical Corp is a U.S.-based home medical equipment provider specializing in respiratory care, sleep therapy supplies, and chronic disease management products. It serves patients with long-term health conditions, partners with healthcare providers and insurance payers across operating regions to deliver accessible in-home medical solutions.

MED vs QIPT — Head-to-Head

Bigger by revenue
MED
MED
1.5× larger
MED
$75.1M
$49.0M
QIPT
Growing faster (revenue YoY)
QIPT
QIPT
+69.1% gap
QIPT
32.3%
-36.9%
MED
More free cash flow
QIPT
QIPT
$13.5M more FCF
QIPT
$6.9M
$-6.6M
MED

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MED
MED
QIPT
QIPT
Revenue
$75.1M
$49.0M
Net Profit
$-1.1M
Gross Margin
69.4%
53.5%
Operating Margin
-10.4%
2.1%
Net Margin
-2.1%
Revenue YoY
-36.9%
32.3%
Net Profit YoY
2.9%
EPS (diluted)
$-1.64
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
QIPT
QIPT
Q4 25
$75.1M
$49.0M
Q3 25
$89.4M
$39.8M
Q2 25
$105.6M
$35.1M
Q1 25
$115.7M
$33.3M
Q4 24
$119.0M
$37.1M
Q3 24
$140.2M
Q2 24
$168.6M
Q1 24
$174.7M
Net Profit
MED
MED
QIPT
QIPT
Q4 25
$-1.1M
Q3 25
$-2.3M
$-3.5M
Q2 25
$2.5M
$-3.0M
Q1 25
$-772.0K
$-3.0M
Q4 24
$-1.1M
Q3 24
$1.1M
Q2 24
$-8.2M
Q1 24
$8.3M
Gross Margin
MED
MED
QIPT
QIPT
Q4 25
69.4%
53.5%
Q3 25
69.5%
48.7%
Q2 25
72.6%
57.6%
Q1 25
72.8%
54.6%
Q4 24
74.1%
52.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
MED
MED
QIPT
QIPT
Q4 25
-10.4%
2.1%
Q3 25
-4.6%
-3.6%
Q2 25
-1.0%
-5.2%
Q1 25
-1.1%
-3.0%
Q4 24
0.6%
1.2%
Q3 24
1.5%
Q2 24
-4.7%
Q1 24
4.5%
Net Margin
MED
MED
QIPT
QIPT
Q4 25
-2.1%
Q3 25
-2.5%
-8.9%
Q2 25
2.3%
-8.6%
Q1 25
-0.7%
-9.1%
Q4 24
-2.9%
Q3 24
0.8%
Q2 24
-4.8%
Q1 24
4.8%
EPS (diluted)
MED
MED
QIPT
QIPT
Q4 25
$-1.64
$-0.02
Q3 25
$-0.21
$-0.07
Q2 25
$0.22
$-0.07
Q1 25
$-0.07
$-0.07
Q4 24
$0.08
$-0.03
Q3 24
$0.10
Q2 24
$-0.75
Q1 24
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
QIPT
QIPT
Cash + ST InvestmentsLiquidity on hand
$167.3M
$10.5M
Total DebtLower is stronger
$84.0M
Stockholders' EquityBook value
$198.9M
$113.0M
Total Assets
$248.0M
$280.7M
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
QIPT
QIPT
Q4 25
$167.3M
$10.5M
Q3 25
$173.5M
$12.9M
Q2 25
$162.7M
$11.3M
Q1 25
$164.6M
$17.1M
Q4 24
$162.3M
$15.5M
Q3 24
$170.0M
Q2 24
$163.5M
Q1 24
$156.4M
Total Debt
MED
MED
QIPT
QIPT
Q4 25
$84.0M
Q3 25
$87.6M
Q2 25
$66.0M
Q1 25
$71.5M
Q4 24
$70.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MED
MED
QIPT
QIPT
Q4 25
$198.9M
$113.0M
Q3 25
$214.7M
$112.1M
Q2 25
$216.0M
$102.5M
Q1 25
$211.0M
$103.6M
Q4 24
$210.1M
$106.3M
Q3 24
$207.3M
Q2 24
$205.3M
Q1 24
$211.0M
Total Assets
MED
MED
QIPT
QIPT
Q4 25
$248.0M
$280.7M
Q3 25
$268.2M
$283.3M
Q2 25
$269.3M
$236.1M
Q1 25
$280.0M
$244.6M
Q4 24
$284.2M
$242.8M
Q3 24
$291.2M
Q2 24
$293.5M
Q1 24
$302.8M
Debt / Equity
MED
MED
QIPT
QIPT
Q4 25
0.74×
Q3 25
0.78×
Q2 25
0.64×
Q1 25
0.69×
Q4 24
0.66×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
QIPT
QIPT
Operating Cash FlowLast quarter
$-5.3M
$8.9M
Free Cash FlowOCF − Capex
$-6.6M
$6.9M
FCF MarginFCF / Revenue
-8.8%
14.0%
Capex IntensityCapex / Revenue
1.8%
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$26.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
QIPT
QIPT
Q4 25
$-5.3M
$8.9M
Q3 25
$12.1M
$9.8M
Q2 25
$-3.4M
$9.7M
Q1 25
$3.4M
$8.9M
Q4 24
$-4.9M
$9.3M
Q3 24
$9.1M
Q2 24
$13.1M
Q1 24
$7.3M
Free Cash Flow
MED
MED
QIPT
QIPT
Q4 25
$-6.6M
$6.9M
Q3 25
$10.8M
$8.0M
Q2 25
$-4.8M
$4.4M
Q1 25
$1.9M
$7.3M
Q4 24
$-7.2M
$5.6M
Q3 24
$7.7M
Q2 24
$11.1M
Q1 24
$5.4M
FCF Margin
MED
MED
QIPT
QIPT
Q4 25
-8.8%
14.0%
Q3 25
12.0%
20.0%
Q2 25
-4.5%
12.6%
Q1 25
1.6%
22.0%
Q4 24
-6.1%
15.2%
Q3 24
5.5%
Q2 24
6.6%
Q1 24
3.1%
Capex Intensity
MED
MED
QIPT
QIPT
Q4 25
1.8%
4.2%
Q3 25
1.5%
4.6%
Q2 25
1.3%
14.9%
Q1 25
1.3%
4.8%
Q4 24
1.9%
9.9%
Q3 24
1.0%
Q2 24
1.1%
Q1 24
1.1%
Cash Conversion
MED
MED
QIPT
QIPT
Q4 25
Q3 25
Q2 25
-1.36×
Q1 25
Q4 24
Q3 24
8.04×
Q2 24
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons